Frankie Holmes
4PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 30, 2020
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.Denis M Collins, Stephen F Madden, Nicola Gaynor
|Sep 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast Cancer.Ian Krop, Vandana Abramson, Marco Colleoni
|Nov 01, 2019
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.Devchand Paul, Svetislava J Vukelja, Frankie Ann Holmes
|Mar 28, 2018
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.Frankie Ann Holmes, Beth A Hellerstedt, John E Pippen
Pageof 1
Frequent Collaborators
1 joint publications
Denis M Collins
1 joint publications
Alex J Eustace
1 joint publications
Sinead Toomey
1 joint publications
Darran P O'Connor
1 joint publications
William M Gallagher
1 joint publications
Virginia Espina
1 joint publications
Kenneth J O'Byrne
1 joint publications
Max Hasmann
1 joint publications
Vandana Abramson
1 joint publications
Ahmad Awada
